Tissue augmentation

"Tissue augmentation" refers broadly to clinical and biomedical techniques for restoring or increasing tissue volume, especially in the skin and subcutaneous layers. These interventions include dermal fillers (synthetic or biological), cell-based implants (e.g., cultured fibroblasts, adipose-derived stem/stromal cells), and engineered scaffolds designed to stimulate regeneration. Common indications include cosmetic applications for aging skin, repair of traumatic or iatrogenic defects, and treatment of lipoatrophic conditions such as metabolic disorders or HIV-associated fat loss. Mechanisms rely mainly on biomaterial volume effects, cellular matrix remodeling, and local signal transduction by growth factors such as EGF, TGF-β, FGF, PDGF, and VEGF, acting through their cognate receptors in target cells (fibroblasts, keratinocytes, etc.)[1][2][3][4]. Safety concerns include allergic reactions, infection, unpredictable resorption, and adverse tissue responses. "Tissue augmentation" should not be treated as a molecule or drug target—if you need information about specific molecular targets used within tissue augmentation (e.g., growth factor receptors, extracellular matrix proteins), those should be explicitly named for structured annotation.

Other names

Soft tissue augmentationinjectable tissue augmentationdermal filler augmentationtissue-engineered augmentation

Biomaterials physically restore volume by occupying space Cellular therapies promote regeneration by stimulating extracellular matrix production and tissue remodeling through growth factor signaling[2][3][4] Scaffold-based approaches can promote cell recruitment, differentiation, and integration into host tissue[4]